Managing immune-mediated diseases in cats requires careful balance between disease control and immunosuppressive side effects.
Cats receiving inappropriate immunosuppressive doses suffer from both under-treated disease and drug side effects. Careful dose titration guided by clinical response and monitoring achieves the best welfare outcome by balancing disease control with drug tolerance.